1h Free Analyst Time
The global liver cancer drugs market is forecasted to grow by USD 4.01 billion during 2025-2030, accelerating at a CAGR of 10.2% during the forecast period. The report on the global liver cancer drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating global incidence of hepatocellular carcinoma and primary malignancies, rapid proliferation and approval of novel combination immunotherapies, increasing deployment of precision biomarkers and targeted small molecule inhibitors.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global liver cancer drugs market is segmented as below:
By Type
- Immunotherapy
- Targeted therapy
By Drug Class
- Targeted therapy drugs
- Immunotherapy drugs
- Chemotherapeutics
- Others
By Route Of Administration
- Oral
- Injectable
- Others
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (RoW)
- Rest of World (RoW)
The report on the global liver cancer drugs market covers the following areas:
- Global liver cancer drugs market sizing
- Global liver cancer drugs market forecast
- Global liver cancer drugs market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Liver Cancer Drugs Market 2020 - 2024
- Historic Market Size - Data Table on Global Liver Cancer Drugs Market 2020 - 2024 ($ million)
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on global liver cancer drugs market
6.2 Impact of geopolitical conflicts on global liver cancer drugs market
6.2 Impact of geopolitical conflicts on global liver cancer drugs market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Type
8.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
- Chart on Comparison by Type
- Data Table on Comparison by Type
- Chart on Immunotherapy - Market size and forecast 2025-2030 ($ million)
- Data Table on Immunotherapy - Market size and forecast 2025-2030 ($ million)
- Chart on Immunotherapy - Year-over-year growth 2025-2030 (%)
- Data Table on Immunotherapy - Year-over-year growth 2025-2030 (%)
- Chart on Targeted therapy - Market size and forecast 2025-2030 ($ million)
- Data Table on Targeted therapy - Market size and forecast 2025-2030 ($ million)
- Chart on Targeted therapy - Year-over-year growth 2025-2030 (%)
- Data Table on Targeted therapy - Year-over-year growth 2025-2030 (%)
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Drug Class
9.1 Market segments
- Chart on Drug Class - Market share 2025-2030 (%)
- Data Table on Drug Class - Market share 2025-2030 (%)
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- Chart on Targeted therapy drugs - Market size and forecast 2025-2030 ($ million)
- Data Table on Targeted therapy drugs - Market size and forecast 2025-2030 ($ million)
- Chart on Targeted therapy drugs - Year-over-year growth 2025-2030 (%)
- Data Table on Targeted therapy drugs - Year-over-year growth 2025-2030 (%)
- Chart on Immunotherapy drugs - Market size and forecast 2025-2030 ($ million)
- Data Table on Immunotherapy drugs - Market size and forecast 2025-2030 ($ million)
- Chart on Immunotherapy drugs - Year-over-year growth 2025-2030 (%)
- Data Table on Immunotherapy drugs - Year-over-year growth 2025-2030 (%)
- Chart on Chemotherapeutics - Market size and forecast 2025-2030 ($ million)
- Data Table on Chemotherapeutics - Market size and forecast 2025-2030 ($ million)
- Chart on Chemotherapeutics - Year-over-year growth 2025-2030 (%)
- Data Table on Chemotherapeutics - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
10 Market Segmentation by Route of Administration
10.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Oral - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral - Market size and forecast 2025-2030 ($ million)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
- Chart on Injectable - Market size and forecast 2025-2030 ($ million)
- Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
- Chart on Injectable - Year-over-year growth 2025-2030 (%)
- Data Table on Injectable - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
11 Market Segmentation by Distribution Channel
11.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
- Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
- Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
12 Customer Landscape
12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
13.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ million)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ million)
- Data Table on Israel - Market size and forecast 2025-2030 ($ million)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
14 Drivers, Challenges, and Opportunity
14.1 Market drivers
- Escalating global incidence of hepatocellular carcinoma and primary malignancies
- Rapid proliferation and approval of novel combination immunotherapies
- Increasing deployment of precision biomarkers and targeted small molecule inhibitors
- Severe financial toxicity and regulatory disparities impacting patient access
- Inherent biological heterogeneity and rapid emergence of therapeutic resistance mechanisms
- Complex under-diagnosis patterns and high co-morbidity profiles in cirrhotic populations
- Impact of drivers and challenges in 2025 and 2030
- Systematic shift from conventional monotherapies to complex combination protocols
- Growing integration of biomarker-driven diagnostics and precision medicine frameworks
- Rapid expansion and localization of biosimilars in developing regional economies
15 Competitive Landscape
15.1 Overview
15.2 Competitive Landscape
15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
16 Competitive Analysis
16.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Business segments
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- AstraZeneca Plc - Segment focus
- SWOT
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
- Dr. Reddys Laboratories Ltd. - Overview
- Dr. Reddys Laboratories Ltd. - Business segments
- Dr. Reddys Laboratories Ltd. - Key news
- Dr. Reddys Laboratories Ltd. - Key offerings
- Dr. Reddys Laboratories Ltd. - Segment focus
- SWOT
- Eisai Co. Ltd. - Overview
- Eisai Co. Ltd. - Business segments
- Eisai Co. Ltd. - Key offerings
- Eisai Co. Ltd. - Segment focus
- SWOT
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
- Exelixis Inc. - Overview
- Exelixis Inc. - Product / Service
- Exelixis Inc. - Key offerings
- SWOT
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- Ipsen Pharma - Overview
- Ipsen Pharma - Business segments
- Ipsen Pharma - Key offerings
- Ipsen Pharma - Segment focus
- SWOT
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- Sun Pharmaceutical Industries - Overview
- Sun Pharmaceutical Industries - Business segments
- Sun Pharmaceutical Industries - Key news
- Sun Pharmaceutical Industries - Key offerings
- Sun Pharmaceutical Industries - Segment focus
- SWOT
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
- Zelgen Biopharmaceuticals - Overview
- Zelgen Biopharmaceuticals - Product / Service
- Zelgen Biopharmaceuticals - Key offerings
- SWOT
17 Appendix
17.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 9: Executive Summary - Chart on Incremental Growth
Exhibit 10: Executive Summary - Data Table on Incremental Growth
Exhibit 11: Executive Summary - Chart on Company Market Positioning
Exhibit 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 13: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 14: Chart on Overview on factors of disruption
Exhibit 15: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 16: Chart on Parent Market
Exhibit 17: Data Table on - Parent Market
Exhibit 18: Chart on Market characteristics analysis
Exhibit 19: Chart on Value chain analysis
Exhibit 20: Data Table on Offerings of companies included in the market definition
Exhibit 21: Market segments
Exhibit 22: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 24: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 26: Historic Market Size - Data Table on Global Liver Cancer Drugs Market 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 31: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 32: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 33: Five forces analysis - Comparison between 2025 and 2030
Exhibit 34: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 37: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 38: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 39: Chart on Market condition - Five forces 2025 and 2030
Exhibit 40: Chart on Type - Market share 2025-2030 (%)
Exhibit 41: Data Table on Type - Market share 2025-2030 (%)
Exhibit 42: Chart on Comparison by Type
Exhibit 43: Data Table on Comparison by Type
Exhibit 44: Chart on Immunotherapy - Market size and forecast 2025-2030 ($ million)
Exhibit 45: Data Table on Immunotherapy - Market size and forecast 2025-2030 ($ million)
Exhibit 46: Chart on Immunotherapy - Year-over-year growth 2025-2030 (%)
Exhibit 47: Data Table on Immunotherapy - Year-over-year growth 2025-2030 (%)
Exhibit 48: Chart on Targeted therapy - Market size and forecast 2025-2030 ($ million)
Exhibit 49: Data Table on Targeted therapy - Market size and forecast 2025-2030 ($ million)
Exhibit 50: Chart on Targeted therapy - Year-over-year growth 2025-2030 (%)
Exhibit 51: Data Table on Targeted therapy - Year-over-year growth 2025-2030 (%)
Exhibit 52: Market opportunity by Type ($ million)
Exhibit 53: Data Table on Market opportunity by Type ($ million)
Exhibit 54: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 55: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 56: Chart on Comparison by Drug Class
Exhibit 57: Data Table on Comparison by Drug Class
Exhibit 58: Chart on Targeted therapy drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 59: Data Table on Targeted therapy drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 60: Chart on Targeted therapy drugs - Year-over-year growth 2025-2030 (%)
Exhibit 61: Data Table on Targeted therapy drugs - Year-over-year growth 2025-2030 (%)
Exhibit 62: Chart on Immunotherapy drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 63: Data Table on Immunotherapy drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 64: Chart on Immunotherapy drugs - Year-over-year growth 2025-2030 (%)
Exhibit 65: Data Table on Immunotherapy drugs - Year-over-year growth 2025-2030 (%)
Exhibit 66: Chart on Chemotherapeutics - Market size and forecast 2025-2030 ($ million)
Exhibit 67: Data Table on Chemotherapeutics - Market size and forecast 2025-2030 ($ million)
Exhibit 68: Chart on Chemotherapeutics - Year-over-year growth 2025-2030 (%)
Exhibit 69: Data Table on Chemotherapeutics - Year-over-year growth 2025-2030 (%)
Exhibit 70: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 71: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 72: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 74: Market opportunity by Drug Class ($ million)
Exhibit 75: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 76: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 77: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 78: Chart on Comparison by Route of Administration
Exhibit 79: Data Table on Comparison by Route of Administration
Exhibit 80: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 81: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 82: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 83: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 84: Chart on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 85: Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 86: Chart on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 87: Data Table on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 88: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 89: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 90: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 91: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 92: Market opportunity by Route of Administration ($ million)
Exhibit 93: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 94: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 95: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 96: Chart on Comparison by Distribution Channel
Exhibit 97: Data Table on Comparison by Distribution Channel
Exhibit 98: Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 99: Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 101: Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 102: Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 103: Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 105: Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 106: Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 107: Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 109: Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 110: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 111: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 113: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 114: Market opportunity by Distribution Channel ($ million)
Exhibit 115: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 116: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 117: Chart on Market share by geography 2025-2030 (%)
Exhibit 118: Data Table on Market share by geography 2025-2030 (%)
Exhibit 119: Chart on Geographic comparison
Exhibit 120: Data Table on Geographic comparison
Exhibit 121: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on Regional Comparison - North America
Exhibit 126: Data Table on Regional Comparison - North America
Exhibit 127: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 128: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 129: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 130: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 131: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 132: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 133: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 134: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 135: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 136: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 137: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 138: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 139: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 140: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 141: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 142: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 143: Chart on Regional Comparison - Europe
Exhibit 144: Data Table on Regional Comparison - Europe
Exhibit 145: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 159: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 162: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 163: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 166: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 167: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 168: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 169: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 170: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 171: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 172: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 173: Chart on Regional Comparison - Asia
Exhibit 174: Data Table on Regional Comparison - Asia
Exhibit 175: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 188: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 189: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 196: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 197: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 200: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 201: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 202: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 203: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 204: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 205: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 222: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 223: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 225: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 226: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 227: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 229: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 230: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 231: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 232: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 233: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 234: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 235: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 236: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 237: Market opportunity by geography ($ million)
Exhibit 238: Data Tables on Market opportunity by geography ($ million)
Exhibit 239: Impact of drivers and challenges in 2025 and 2030
Exhibit 240: Overview on criticality of inputs and factors of differentiation
Exhibit 241: Overview on factors of disruption
Exhibit 242: Impact of key risks on business
Exhibit 243: Companies covered
Exhibit 244: Company ranking index
Exhibit 245: Matrix on companies position and classification
Exhibit 246: AstraZeneca Plc - Overview
Exhibit 247: AstraZeneca Plc - Business segments
Exhibit 248: AstraZeneca Plc - Key news
Exhibit 249: AstraZeneca Plc - Key offerings
Exhibit 250: AstraZeneca Plc - Segment focus
Exhibit 251: SWOT
Exhibit 252: Bayer AG - Overview
Exhibit 253: Bayer AG - Business segments
Exhibit 254: Bayer AG - Key offerings
Exhibit 255: Bayer AG - Segment focus
Exhibit 256: SWOT
Exhibit 257: Bristol Myers Squibb Co. - Overview
Exhibit 258: Bristol Myers Squibb Co. - Product / Service
Exhibit 259: Bristol Myers Squibb Co. - Key news
Exhibit 260: Bristol Myers Squibb Co. - Key offerings
Exhibit 261: SWOT
Exhibit 262: Cipla Inc. - Overview
Exhibit 263: Cipla Inc. - Business segments
Exhibit 264: Cipla Inc. - Key news
Exhibit 265: Cipla Inc. - Key offerings
Exhibit 266: Cipla Inc. - Segment focus
Exhibit 267: SWOT
Exhibit 268: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 269: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 270: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 271: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 272: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 273: SWOT
Exhibit 274: Eisai Co. Ltd. - Overview
Exhibit 275: Eisai Co. Ltd. - Business segments
Exhibit 276: Eisai Co. Ltd. - Key offerings
Exhibit 277: Eisai Co. Ltd. - Segment focus
Exhibit 278: SWOT
Exhibit 279: Eli Lilly and Co. - Overview
Exhibit 280: Eli Lilly and Co. - Product / Service
Exhibit 281: Eli Lilly and Co. - Key offerings
Exhibit 282: SWOT
Exhibit 283: Exelixis Inc. - Overview
Exhibit 284: Exelixis Inc. - Product / Service
Exhibit 285: Exelixis Inc. - Key offerings
Exhibit 286: SWOT
Exhibit 287: F. Hoffmann La Roche Ltd. - Overview
Exhibit 288: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 289: F. Hoffmann La Roche Ltd. - Key news
Exhibit 290: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 291: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 292: SWOT
Exhibit 293: Ipsen Pharma - Overview
Exhibit 294: Ipsen Pharma - Business segments
Exhibit 295: Ipsen Pharma - Key offerings
Exhibit 296: Ipsen Pharma - Segment focus
Exhibit 297: SWOT
Exhibit 298: Merck and Co. Inc. - Overview
Exhibit 299: Merck and Co. Inc. - Business segments
Exhibit 300: Merck and Co. Inc. - Key news
Exhibit 301: Merck and Co. Inc. - Key offerings
Exhibit 302: Merck and Co. Inc. - Segment focus
Exhibit 303: SWOT
Exhibit 304: Sun Pharmaceutical Industries - Overview
Exhibit 305: Sun Pharmaceutical Industries - Business segments
Exhibit 306: Sun Pharmaceutical Industries - Key news
Exhibit 307: Sun Pharmaceutical Industries - Key offerings
Exhibit 308: Sun Pharmaceutical Industries - Segment focus
Exhibit 309: SWOT
Exhibit 310: Teva Pharmaceutical Ltd. - Overview
Exhibit 311: Teva Pharmaceutical Ltd. - Business segments
Exhibit 312: Teva Pharmaceutical Ltd. - Key news
Exhibit 313: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 314: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 315: SWOT
Exhibit 316: Viatris Inc. - Overview
Exhibit 317: Viatris Inc. - Business segments
Exhibit 318: Viatris Inc. - Key news
Exhibit 319: Viatris Inc. - Key offerings
Exhibit 320: Viatris Inc. - Segment focus
Exhibit 321: SWOT
Exhibit 322: Zelgen Biopharmaceuticals - Overview
Exhibit 323: Zelgen Biopharmaceuticals - Product / Service
Exhibit 324: Zelgen Biopharmaceuticals - Key offerings
Exhibit 325: SWOT
Exhibit 326: Inclusions checklist
Exhibit 327: Exclusions checklist
Exhibit 328: Currency conversion rates for US$
Exhibit 329: Research methodology
Exhibit 330: Information sources
Exhibit 331: Data validation
Exhibit 332: Validation techniques employed for market sizing
Exhibit 333: Data synthesis
Exhibit 334: 360 degree market analysis
Exhibit 335: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 9: Executive Summary - Chart on Incremental Growth
Exhibit 10: Executive Summary - Data Table on Incremental Growth
Exhibit 11: Executive Summary - Chart on Company Market Positioning
Exhibit 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 13: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 14: Chart on Overview on factors of disruption
Exhibit 15: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 16: Chart on Parent Market
Exhibit 17: Data Table on - Parent Market
Exhibit 18: Chart on Market characteristics analysis
Exhibit 19: Chart on Value chain analysis
Exhibit 20: Data Table on Offerings of companies included in the market definition
Exhibit 21: Market segments
Exhibit 22: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 24: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 26: Historic Market Size - Data Table on Global Liver Cancer Drugs Market 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 31: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 32: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 33: Five forces analysis - Comparison between 2025 and 2030
Exhibit 34: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 37: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 38: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 39: Chart on Market condition - Five forces 2025 and 2030
Exhibit 40: Chart on Type - Market share 2025-2030 (%)
Exhibit 41: Data Table on Type - Market share 2025-2030 (%)
Exhibit 42: Chart on Comparison by Type
Exhibit 43: Data Table on Comparison by Type
Exhibit 44: Chart on Immunotherapy - Market size and forecast 2025-2030 ($ million)
Exhibit 45: Data Table on Immunotherapy - Market size and forecast 2025-2030 ($ million)
Exhibit 46: Chart on Immunotherapy - Year-over-year growth 2025-2030 (%)
Exhibit 47: Data Table on Immunotherapy - Year-over-year growth 2025-2030 (%)
Exhibit 48: Chart on Targeted therapy - Market size and forecast 2025-2030 ($ million)
Exhibit 49: Data Table on Targeted therapy - Market size and forecast 2025-2030 ($ million)
Exhibit 50: Chart on Targeted therapy - Year-over-year growth 2025-2030 (%)
Exhibit 51: Data Table on Targeted therapy - Year-over-year growth 2025-2030 (%)
Exhibit 52: Market opportunity by Type ($ million)
Exhibit 53: Data Table on Market opportunity by Type ($ million)
Exhibit 54: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 55: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 56: Chart on Comparison by Drug Class
Exhibit 57: Data Table on Comparison by Drug Class
Exhibit 58: Chart on Targeted therapy drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 59: Data Table on Targeted therapy drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 60: Chart on Targeted therapy drugs - Year-over-year growth 2025-2030 (%)
Exhibit 61: Data Table on Targeted therapy drugs - Year-over-year growth 2025-2030 (%)
Exhibit 62: Chart on Immunotherapy drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 63: Data Table on Immunotherapy drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 64: Chart on Immunotherapy drugs - Year-over-year growth 2025-2030 (%)
Exhibit 65: Data Table on Immunotherapy drugs - Year-over-year growth 2025-2030 (%)
Exhibit 66: Chart on Chemotherapeutics - Market size and forecast 2025-2030 ($ million)
Exhibit 67: Data Table on Chemotherapeutics - Market size and forecast 2025-2030 ($ million)
Exhibit 68: Chart on Chemotherapeutics - Year-over-year growth 2025-2030 (%)
Exhibit 69: Data Table on Chemotherapeutics - Year-over-year growth 2025-2030 (%)
Exhibit 70: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 71: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 72: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 74: Market opportunity by Drug Class ($ million)
Exhibit 75: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 76: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 77: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 78: Chart on Comparison by Route of Administration
Exhibit 79: Data Table on Comparison by Route of Administration
Exhibit 80: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 81: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 82: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 83: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 84: Chart on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 85: Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 86: Chart on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 87: Data Table on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 88: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 89: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 90: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 91: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 92: Market opportunity by Route of Administration ($ million)
Exhibit 93: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 94: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 95: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 96: Chart on Comparison by Distribution Channel
Exhibit 97: Data Table on Comparison by Distribution Channel
Exhibit 98: Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 99: Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 101: Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 102: Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 103: Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 105: Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 106: Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 107: Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 109: Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 110: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 111: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 113: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 114: Market opportunity by Distribution Channel ($ million)
Exhibit 115: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 116: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 117: Chart on Market share by geography 2025-2030 (%)
Exhibit 118: Data Table on Market share by geography 2025-2030 (%)
Exhibit 119: Chart on Geographic comparison
Exhibit 120: Data Table on Geographic comparison
Exhibit 121: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on Regional Comparison - North America
Exhibit 126: Data Table on Regional Comparison - North America
Exhibit 127: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 128: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 129: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 130: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 131: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 132: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 133: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 134: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 135: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 136: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 137: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 138: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 139: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 140: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 141: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 142: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 143: Chart on Regional Comparison - Europe
Exhibit 144: Data Table on Regional Comparison - Europe
Exhibit 145: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 159: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 162: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 163: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 166: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 167: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 168: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 169: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 170: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 171: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 172: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 173: Chart on Regional Comparison - Asia
Exhibit 174: Data Table on Regional Comparison - Asia
Exhibit 175: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 188: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 189: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 196: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 197: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 200: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 201: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 202: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 203: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 204: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 205: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 222: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 223: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 225: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 226: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 227: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 229: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 230: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 231: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 232: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 233: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 234: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 235: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 236: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 237: Market opportunity by geography ($ million)
Exhibit 238: Data Tables on Market opportunity by geography ($ million)
Exhibit 239: Impact of drivers and challenges in 2025 and 2030
Exhibit 240: Overview on criticality of inputs and factors of differentiation
Exhibit 241: Overview on factors of disruption
Exhibit 242: Impact of key risks on business
Exhibit 243: Companies covered
Exhibit 244: Company ranking index
Exhibit 245: Matrix on companies position and classification
Exhibit 246: AstraZeneca Plc - Overview
Exhibit 247: AstraZeneca Plc - Business segments
Exhibit 248: AstraZeneca Plc - Key news
Exhibit 249: AstraZeneca Plc - Key offerings
Exhibit 250: AstraZeneca Plc - Segment focus
Exhibit 251: SWOT
Exhibit 252: Bayer AG - Overview
Exhibit 253: Bayer AG - Business segments
Exhibit 254: Bayer AG - Key offerings
Exhibit 255: Bayer AG - Segment focus
Exhibit 256: SWOT
Exhibit 257: Bristol Myers Squibb Co. - Overview
Exhibit 258: Bristol Myers Squibb Co. - Product / Service
Exhibit 259: Bristol Myers Squibb Co. - Key news
Exhibit 260: Bristol Myers Squibb Co. - Key offerings
Exhibit 261: SWOT
Exhibit 262: Cipla Inc. - Overview
Exhibit 263: Cipla Inc. - Business segments
Exhibit 264: Cipla Inc. - Key news
Exhibit 265: Cipla Inc. - Key offerings
Exhibit 266: Cipla Inc. - Segment focus
Exhibit 267: SWOT
Exhibit 268: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 269: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 270: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 271: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 272: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 273: SWOT
Exhibit 274: Eisai Co. Ltd. - Overview
Exhibit 275: Eisai Co. Ltd. - Business segments
Exhibit 276: Eisai Co. Ltd. - Key offerings
Exhibit 277: Eisai Co. Ltd. - Segment focus
Exhibit 278: SWOT
Exhibit 279: Eli Lilly and Co. - Overview
Exhibit 280: Eli Lilly and Co. - Product / Service
Exhibit 281: Eli Lilly and Co. - Key offerings
Exhibit 282: SWOT
Exhibit 283: Exelixis Inc. - Overview
Exhibit 284: Exelixis Inc. - Product / Service
Exhibit 285: Exelixis Inc. - Key offerings
Exhibit 286: SWOT
Exhibit 287: F. Hoffmann La Roche Ltd. - Overview
Exhibit 288: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 289: F. Hoffmann La Roche Ltd. - Key news
Exhibit 290: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 291: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 292: SWOT
Exhibit 293: Ipsen Pharma - Overview
Exhibit 294: Ipsen Pharma - Business segments
Exhibit 295: Ipsen Pharma - Key offerings
Exhibit 296: Ipsen Pharma - Segment focus
Exhibit 297: SWOT
Exhibit 298: Merck and Co. Inc. - Overview
Exhibit 299: Merck and Co. Inc. - Business segments
Exhibit 300: Merck and Co. Inc. - Key news
Exhibit 301: Merck and Co. Inc. - Key offerings
Exhibit 302: Merck and Co. Inc. - Segment focus
Exhibit 303: SWOT
Exhibit 304: Sun Pharmaceutical Industries - Overview
Exhibit 305: Sun Pharmaceutical Industries - Business segments
Exhibit 306: Sun Pharmaceutical Industries - Key news
Exhibit 307: Sun Pharmaceutical Industries - Key offerings
Exhibit 308: Sun Pharmaceutical Industries - Segment focus
Exhibit 309: SWOT
Exhibit 310: Teva Pharmaceutical Ltd. - Overview
Exhibit 311: Teva Pharmaceutical Ltd. - Business segments
Exhibit 312: Teva Pharmaceutical Ltd. - Key news
Exhibit 313: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 314: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 315: SWOT
Exhibit 316: Viatris Inc. - Overview
Exhibit 317: Viatris Inc. - Business segments
Exhibit 318: Viatris Inc. - Key news
Exhibit 319: Viatris Inc. - Key offerings
Exhibit 320: Viatris Inc. - Segment focus
Exhibit 321: SWOT
Exhibit 322: Zelgen Biopharmaceuticals - Overview
Exhibit 323: Zelgen Biopharmaceuticals - Product / Service
Exhibit 324: Zelgen Biopharmaceuticals - Key offerings
Exhibit 325: SWOT
Exhibit 326: Inclusions checklist
Exhibit 327: Exclusions checklist
Exhibit 328: Currency conversion rates for US$
Exhibit 329: Research methodology
Exhibit 330: Information sources
Exhibit 331: Data validation
Exhibit 332: Validation techniques employed for market sizing
Exhibit 333: Data synthesis
Exhibit 334: 360 degree market analysis
Exhibit 335: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global liver cancer drugs market: Accord Healthcare Ltd., Apotex Inc., AstraZeneca Plc, Bayer AG, Bristol Myers Squibb Co., Cipla Inc., Dr. Reddys Laboratories Ltd., Eisai Co. Ltd., Eli Lilly and Co., Exelixis Inc., F. Hoffmann La Roche Ltd., Fresenius Kabi AG, Glenmark Pharmaceuticals Ltd., Innovent Biologics Inc., Ipsen Pharma, Merck and Co. Inc., Sun Pharmaceutical Industries, Teva Pharmaceutical Ltd., Viatris Inc., Zelgen Biopharmaceuticals.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is systematic shift from conventional monotherapies to complex combination protocols."
According to the report, one of the major drivers for this market is the escalating global incidence of hepatocellular carcinoma and primary malignancies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Accord Healthcare Ltd.
- Apotex Inc.
- AstraZeneca Plc
- Bayer AG
- Bristol Myers Squibb Co.
- Cipla Inc.
- Dr. Reddys Laboratories Ltd.
- Eisai Co. Ltd.
- Eli Lilly and Co.
- Exelixis Inc.
- F. Hoffmann La Roche Ltd.
- Fresenius Kabi AG
- Glenmark Pharmaceuticals Ltd.
- Innovent Biologics Inc.
- Ipsen Pharma
- Merck and Co. Inc.
- Sun Pharmaceutical Industries
- Teva Pharmaceutical Ltd.
- Viatris Inc.
- Zelgen Biopharmaceuticals
